Chuck Royce started to build up the position in GenMark Diagnostics in Q4 2017 and continued to invest until Q1 2018. Since then they sold 103 Thousand shares. The investor completely sold their stake between Q2 2018 and Q3 2020.
Avg closing price
Price range
Sold -12 Thousand shares
Q3 2020
Avg closing price
$15.28
Price range
$11.24
-
$19.10
Sold 61.4% shares (-19.1 Thousand shares)
Q2 2020
Avg closing price
$10.16
Price range
$4.19
-
$14.71
Sold 59.1% shares (-45 Thousand shares)
Q3 2019
Avg closing price
$6.24
Price range
$5.74
-
$6.73
Sold 14.2% shares (-12.6 Thousand shares)
Q4 2018
Avg closing price
$5.21
Price range
$3.74
-
$7.00
Sold 14.2% shares (-14.7 Thousand shares)
Q2 2018
Avg closing price
$6.61
Price range
$5.02
-
$7.70
Increased shares by 56.9% (+37.5 Thousand shares)
Q1 2018